Literature DB >> 6436100

The production and evaluation of a buffered plate antigen for use in a presumptive test for brucellosis.

R D Angus, C E Barton.   

Abstract

A buffered Brucella plate antigen, pH 4.0, was developed for testing bovine and porcine sera which markedly reduced the number of "nonspecific" plate agglutination test reactions. Use of this antigen in a presumptive test decreased testing costs by lowering the amount of "nonspecific" reaction obtained on the standard plate agglutination test and reducing the use of the card test. The test is slightly more sensitive than the card test. Specificity and sensitivity were evaluated using sera collected from experimentally vaccinated and/or infected animals and from animals at slaughter. The antigen is currently being used in a presumptive test for brucellosis in the United States.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436100

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  8 in total

1.  Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle.

Authors:  F A Uza; L Samartino; G Schurig; A Carrasco; K Nielsen; R F Cabrera; H R Taddeo
Journal:  Vet Res Commun       Date:  2000-04       Impact factor: 2.459

2.  Buffered plate antigen test as a screening test for diagnosis of human brucellosis.

Authors:  N E Lucero; J E Bolpe
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

3.  Evaluation of primary binding assays for presumptive serodiagnosis of swine brucellosis in Argentina.

Authors:  P S Paulo; A M Vigliocco; R F Ramondino; D Marticorena; E Bissi; G Briones; C Gorchs; D Gall; K Nielsen
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

4.  Rapid, field-adapted indirect enzyme-linked immunosorbent assay for detection of antibodies in bovine whole blood and serum to Brucella abortus.

Authors:  D Gall; K Nielsen; W Yu; P Smith
Journal:  Clin Vaccine Immunol       Date:  2006-04

5.  The use of divalent cation chelating agents (EDTA/EGTA) to reduce non-specific serum protein interaction in enzyme immunoassay.

Authors:  K Nielsen; L Kelly; D Gall; P Smith; J Bosse; P Nicoletti; W Kelly
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

6.  Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine.

Authors:  Juan Esteban Ugalde; Diego José Comerci; M Susana Leguizamón; Rodolfo Augusto Ugalde
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Characterization of an atypical biotype of Brucella abortus.

Authors:  M M Garcia; B W Brooks; G M Ruckerbauer; C E Rigby; L B Forbes
Journal:  Can J Vet Res       Date:  1988-07       Impact factor: 1.310

8.  Comparison of four polymerase chain reaction assays for the detection of Brucella spp. in clinical samples from dogs.

Authors:  Eduardo J Boeri; María M Wanke; María J Madariaga; María L Teijeiro; Sebastian A Elena; Marcos D Trangoni
Journal:  Vet World       Date:  2018-02-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.